Gafar Babatunde Bamigbade , Athira Subhash , Mohammed Abdin , Hebah Jarusheh , Basim Abu-Jdayil , Shao-Quan Liu , Giovanni Palmisano , Abdelmoneim Ali , Afaf Kamal Eldin , Mutamed Ayyash
{"title":"Date pomace polysaccharides-capped selenium nanoparticles: Biosynthesis, optimization, physicochemical characterization, biological activities, stability and gut microbiota modulation","authors":"Gafar Babatunde Bamigbade , Athira Subhash , Mohammed Abdin , Hebah Jarusheh , Basim Abu-Jdayil , Shao-Quan Liu , Giovanni Palmisano , Abdelmoneim Ali , Afaf Kamal Eldin , Mutamed Ayyash","doi":"10.1016/j.fhfh.2025.100198","DOIUrl":null,"url":null,"abstract":"<div><div>Selenium nanoparticles (Se-NP<sub>S</sub>) are recognized for their bioavailability and low toxicity, though their inherent instability limits broader applications. This study explored the biosynthesis and functional properties of selenium nanoparticles (Se-NPS) stabilized with date pomace polysaccharides (MPS-NP<sub>S</sub>). The MPS-NP<sub>S</sub> characteristics, digestibility and impact on human gut microbiota were investigated. The MPS-NP<sub>S</sub> were well-stabilized, spherical particles averaging 65.4 nm in size, with PDI (0.032), zeta potential (–21.07 mV) and notable antioxidant activity (82.7 % DPPH, 68.9 % ABTS, 491.0 µg/mL FRAP, and 961.2 µg/mL TAC at 100 mg/L). They also showed concentration-dependent enzyme inhibition: 86.8 % α-amylase, 53.9 % α-glucosidase, and 42.4 % ACE inhibition at 100 mg/L, along with anticancer effects against Caco-2 (32.3 %) and MCF-7 (11.3 %) at 50 mg/L. MPS-NP<sub>S</sub> demonstrated broad antimicrobial activity against <em>E. coli</em> O 157:H7 (84.2 %), <em>S</em>. Typhimurium (82.5 %), <em>S. aureus</em> (77.2 %), and L. <em>monocytogenes</em> (89.24 %) and supported probiotic growth, indicating prebiotic potential. During fecal fermentation, they boosted short-chain fatty acid (SCFA) production and the abundance of SCFA-producing bacteria, including G<em>emmiger formicilis</em> and <em>Bifidobacterium</em> species. These findings suggest MPS-NP<sub>S</sub> as a promising functional ingredient for gut health and dietary supplementation.</div></div>","PeriodicalId":12385,"journal":{"name":"Food Hydrocolloids for Health","volume":"7 ","pages":"Article 100198"},"PeriodicalIF":4.6000,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Food Hydrocolloids for Health","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667025925000044","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, APPLIED","Score":null,"Total":0}
引用次数: 0
Abstract
Selenium nanoparticles (Se-NPS) are recognized for their bioavailability and low toxicity, though their inherent instability limits broader applications. This study explored the biosynthesis and functional properties of selenium nanoparticles (Se-NPS) stabilized with date pomace polysaccharides (MPS-NPS). The MPS-NPS characteristics, digestibility and impact on human gut microbiota were investigated. The MPS-NPS were well-stabilized, spherical particles averaging 65.4 nm in size, with PDI (0.032), zeta potential (–21.07 mV) and notable antioxidant activity (82.7 % DPPH, 68.9 % ABTS, 491.0 µg/mL FRAP, and 961.2 µg/mL TAC at 100 mg/L). They also showed concentration-dependent enzyme inhibition: 86.8 % α-amylase, 53.9 % α-glucosidase, and 42.4 % ACE inhibition at 100 mg/L, along with anticancer effects against Caco-2 (32.3 %) and MCF-7 (11.3 %) at 50 mg/L. MPS-NPS demonstrated broad antimicrobial activity against E. coli O 157:H7 (84.2 %), S. Typhimurium (82.5 %), S. aureus (77.2 %), and L. monocytogenes (89.24 %) and supported probiotic growth, indicating prebiotic potential. During fecal fermentation, they boosted short-chain fatty acid (SCFA) production and the abundance of SCFA-producing bacteria, including Gemmiger formicilis and Bifidobacterium species. These findings suggest MPS-NPS as a promising functional ingredient for gut health and dietary supplementation.